Danaher Corporation (NYSE:DHR) and AstraZeneca PLC (NASDAQ:AZN) have announced a major partnership to accelerate the ...

At ASMS 2025, SCIEX, a global leader in life science analytical technologies and operating company of Danaher Corporation ...

We recently published a list of Was Jim Cramer Right About These 12 Stocks? In this article, we are going to take a look at ...

In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other best healthcare stocks to invest in. Healthcare stocks experienced a challenging year in ...

Danaher Corporation, a key player in Life Sciences, Biotechnology, and Diagnostics, has shown mixed financial performance with recent declines in revenue and net earnings. Despite recent struggles ...

Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An ...

Third Point Management highlighted stocks like Danaher Corporation (NYSE:DHR) in the second quarter 2023 investor letter. Headquartered in Washington, the District of Columbia, Danaher Corporation ...

Danaher Corporation incorporates science and technology and has a market cap of $150B. The company has mixed financials, with its gross profit margin being its strongest and most consistent.

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments ...

The industry as a whole closed the day down 0.2%. By the end of trading, Danaher Corporation fell $1.02 (-1.6%) to $63.68 on average volume. Throughout the day, 3,164,346 shares of Danaher ...

About a year ago, Danaher Corporation's (NYSE: DHR) valuation looked cheap relative to its peers. Of course, when I write peers, I mean its medical, life sciences, and diagnostics peers because ...